233 related articles for article (PubMed ID: 23108783)
21. Therapeutic targeting the loss of the birt-hogg-dube suppressor gene.
Lu X; Wei W; Fenton J; Nahorski MS; Rabai E; Reiman A; Seabra L; Nagy Z; Latif F; Maher ER
Mol Cancer Ther; 2011 Jan; 10(1):80-9. PubMed ID: 21220493
[TBL] [Abstract][Full Text] [Related]
22. Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN.
Hasumi H; Baba M; Hasumi Y; Huang Y; Oh H; Hughes RM; Klein ME; Takikita S; Nagashima K; Schmidt LS; Linehan WM
J Natl Cancer Inst; 2012 Nov; 104(22):1750-64. PubMed ID: 23150719
[TBL] [Abstract][Full Text] [Related]
23. Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-beta signaling.
Hong SB; Oh H; Valera VA; Stull J; Ngo DT; Baba M; Merino MJ; Linehan WM; Schmidt LS
Mol Cancer; 2010 Jun; 9():160. PubMed ID: 20573232
[TBL] [Abstract][Full Text] [Related]
24. Benign clear cell "sugar" tumor of the lung in a patient with Birt-Hogg-Dubé syndrome: a case report.
Gunji-Niitsu Y; Kumasaka T; Kitamura S; Hoshika Y; Hayashi T; Tokuda H; Morita R; Kobayashi E; Mitani K; Kikkawa M; Takahashi K; Seyama K
BMC Med Genet; 2016 Nov; 17(1):85. PubMed ID: 27871249
[TBL] [Abstract][Full Text] [Related]
25. Interaction of folliculin (Birt-Hogg-Dubé gene product) with a novel Fnip1-like (FnipL/Fnip2) protein.
Takagi Y; Kobayashi T; Shiono M; Wang L; Piao X; Sun G; Zhang D; Abe M; Hagiwara Y; Takahashi K; Hino O
Oncogene; 2008 Sep; 27(40):5339-47. PubMed ID: 18663353
[TBL] [Abstract][Full Text] [Related]
26. Establishment and characterization of BHD-F59RSVT, an immortalized cell line derived from a renal cell carcinoma in a patient with Birt-Hogg-Dubé syndrome.
Furuya M; Hasumi H; Baba M; Tanaka R; Iribe Y; Onishi T; Nagashima Y; Nakatani Y; Isono Y; Yao M
Lab Invest; 2017 Mar; 97(3):343-351. PubMed ID: 27991910
[TBL] [Abstract][Full Text] [Related]
27. Birt-Hogg-Dube syndrome is a novel ciliopathy.
Luijten MN; Basten SG; Claessens T; Vernooij M; Scott CL; Janssen R; Easton JA; Kamps MA; Vreeburg M; Broers JL; van Geel M; Menko FH; Harbottle RP; Nookala RK; Tee AR; Land SC; Giles RH; Coull BJ; van Steensel MA
Hum Mol Genet; 2013 Nov; 22(21):4383-97. PubMed ID: 23784378
[TBL] [Abstract][Full Text] [Related]
28. Case Report of Birt-Hogg-Dubé Syndrome: Germline Mutations of FLCN Detected in Patients With Renal Cancer and Thyroid Cancer.
Dong L; Gao M; Hao WJ; Zheng XQ; Li YG; Li XL; Yu Y
Medicine (Baltimore); 2016 May; 95(22):e3695. PubMed ID: 27258496
[TBL] [Abstract][Full Text] [Related]
29. A Case of Birt-Hogg-Dubé (BHD) Syndrome Harboring a Novel Folliculin (FLCN) Gene Mutation.
Yukawa T; Fukazawa T; Yoshida M; Morita I; Kato K; Monobe Y; Furuya M; Naomoto Y
Am J Case Rep; 2016 Oct; 17():788-792. PubMed ID: 27780965
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of pulmonary cyst pathogenesis in Birt-Hogg-Dube syndrome: The stretch hypothesis.
Kennedy JC; Khabibullin D; Henske EP
Semin Cell Dev Biol; 2016 Apr; 52():47-52. PubMed ID: 26877139
[TBL] [Abstract][Full Text] [Related]
31. Heterozygous germline FLCN mutation in Birt-Hogg-Dubé syndrome with bilateral renal hybrid oncocytic/chromophobe tumor and unilateral renal chromophobe cell carcinoma: a case report.
Li J; Liu F; Liu X; Hu Y; Liu Z; Shen Y; Wan J
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2319-2325. PubMed ID: 36258004
[TBL] [Abstract][Full Text] [Related]
32. Birt-Hogg-Dube Syndrome with a Novel Mutation in the FLCN Gene.
Kayhan G; Yılmaz Demirci N; Turktas H; Ergun MA
Genet Test Mol Biomarkers; 2017 Oct; 21(10):632-634. PubMed ID: 28805452
[TBL] [Abstract][Full Text] [Related]
33. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling.
Baba M; Hong SB; Sharma N; Warren MB; Nickerson ML; Iwamatsu A; Esposito D; Gillette WK; Hopkins RF; Hartley JL; Furihata M; Oishi S; Zhen W; Burke TR; Linehan WM; Schmidt LS; Zbar B
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15552-7. PubMed ID: 17028174
[TBL] [Abstract][Full Text] [Related]
34. Birt-Hogg-Dubé syndrome: a literature review and case study of a Chinese woman presenting a novel FLCN mutation.
Hao S; Long F; Sun F; Liu T; Li D; Jiang S
BMC Pulm Med; 2017 Feb; 17(1):43. PubMed ID: 28222720
[TBL] [Abstract][Full Text] [Related]
35. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
[TBL] [Abstract][Full Text] [Related]
36. Birt-Hogg-Dubé syndrome in Korean: clinicoradiologic features and long term follow-up.
Lee JH; Jeon MJ; Song JS; Chae EJ; Choi JH; Kim GH; Song JW
Korean J Intern Med; 2019 Jul; 34(4):830-840. PubMed ID: 30360018
[TBL] [Abstract][Full Text] [Related]
37. H255Y and K508R missense mutations in tumour suppressor folliculin (FLCN) promote kidney cell proliferation.
Hasumi H; Hasumi Y; Baba M; Nishi H; Furuya M; Vocke CD; Lang M; Irie N; Esumi C; Merino MJ; Kawahara T; Isono Y; Makiyama K; Warner AC; Haines DC; Wei MH; Zbar B; Hagenau H; Feigenbaum L; Kondo K; Nakaigawa N; Yao M; Metwalli AR; Marston Linehan W; Schmidt LS
Hum Mol Genet; 2017 Jan; 26(2):354-366. PubMed ID: 28007907
[TBL] [Abstract][Full Text] [Related]
38. Constitutional FLCN mutations in patients with suspected Birt-Hogg-Dubé syndrome ascertained for non-cutaneous manifestations.
Maffé A; Toschi B; Circo G; Giachino D; Giglio S; Rizzo A; Carloni A; Poletti V; Tomassetti S; Ginardi C; Ungari S; Genuardi M
Clin Genet; 2011 Apr; 79(4):345-54. PubMed ID: 20618353
[TBL] [Abstract][Full Text] [Related]
39. Pathology of Birt-Hogg-Dubé syndrome: A special reference of pulmonary manifestations in a Japanese population with a comprehensive analysis and review.
Furuya M; Nakatani Y
Pathol Int; 2019 Jan; 69(1):1-12. PubMed ID: 30632664
[TBL] [Abstract][Full Text] [Related]
40. Nutrient-induced FNIP degradation by SCFβ-TRCP regulates FLCN complex localization and promotes renal cancer progression.
Nagashima K; Fukushima H; Shimizu K; Yamada A; Hidaka M; Hasumi H; Ikebe T; Fukumoto S; Okabe K; Inuzuka H
Oncotarget; 2017 Feb; 8(6):9947-9960. PubMed ID: 28039480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
